Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Non-interventional Study to Evaluate Chemotherapy for Potentially Resectable Locally Advanced Esophagogastric Junction Carcinoma

NCT03211377 is registered in ClinicalTrials.gov with Anyang Tumor Hospital as lead sponsor.

NCT NCT03211377
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03211377 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Non-interventional Study to Evaluate Chemotherapy for Potentially Resectable Locally Advanced Esophagogastric Junction Carcinoma
Lead sponsor
Anyang Tumor Hospital
Phase
Observational
Overall status
Unknown status
Start date
March 29, 2017
Completion date
April 29, 2021
Enrollment
120 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

esophagogastric junction cancer